These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25600415)

  • 1. Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs.
    Beste LA; Ioannou GN
    Epidemiol Rev; 2015; 37():131-43. PubMed ID: 25600415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.
    Belperio PS; Chartier M; Ross DB; Alaigh P; Shulkin D
    Ann Intern Med; 2017 Oct; 167(7):499-504. PubMed ID: 28973196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs.
    Beste LA; Glorioso TJ; Ho PM; Au DH; Kirsh SR; Todd-Stenberg J; Chang MF; Dominitz JA; Barón AE; Ross D
    Am J Med; 2017 Apr; 130(4):432-438.e3. PubMed ID: 27998682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.
    Maier MM; Ross DB; Chartier M; Belperio PS; Backus LI
    Am J Public Health; 2016 Feb; 106(2):353-8. PubMed ID: 26562129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Maier MM; Zhou XH; Chapko M; Leipertz SL; Wang X; Beste LA
    Dig Dis Sci; 2018 Jun; 63(6):1454-1462. PubMed ID: 29453610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System.
    Yeh WS; Armstrong EP; Skrepnek GH; Malone DC
    Pharmacotherapy; 2007 Jun; 27(6):813-24. PubMed ID: 17542764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary care provider perceptions and experiences of implementing hepatitis C virus birth cohort testing: a qualitative formative evaluation.
    Yakovchenko V; Bolton RE; Drainoni ML; Gifford AL
    BMC Health Serv Res; 2019 Apr; 19(1):236. PubMed ID: 31014322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection.
    Rentsch CT; Cartwright EJ; Gandhi NR; Brown ST; Rodriguez-Barradas MC; Goetz MB; Marconi VC; Gibert CL; Re VL; Fiellin DA; Justice AC; Tate JP
    Ann Epidemiol; 2018 Nov; 28(11):808-811. PubMed ID: 30195616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
    Hwang EW; Thomas IC; Cheung R; Backus LI
    J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. User experience of a hepatitis c population management dashboard in the Department of Veterans Affairs.
    Yakovchenko V; Jacob DA; Rogal SS; Morgan TR; Rozenberg-Ben-Dror K
    PLoS One; 2023; 18(5):e0285044. PubMed ID: 37130107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialists.
    Ourth HL; Groppi JA; Morreale AP; Jorgenson T; Himsel AS; Jacob DA
    J Am Pharm Assoc (2003); 2019; 59(3):398-402. PubMed ID: 30853345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Hepatitis C Virus Infection in the Veteran Population Undergoing Total Joint Arthroplasty: An Update.
    Shapiro CBH; Cheung RC; Giori NJ
    J Arthroplasty; 2021 Feb; 36(2):467-470. PubMed ID: 32900563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.
    Belperio PS; Chartier M; Gonzalez RI; Park AM; Ross DB; Morgan TR; Backus LI
    Infect Dis Clin North Am; 2018 Jun; 32(2):281-292. PubMed ID: 29778256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office.
    Yee HS; Chang MF; Pocha C; Lim J; Ross D; Morgan TR; Monto A; ;
    Am J Gastroenterol; 2012 May; 107(5):669-89; quiz 690. PubMed ID: 22525303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
    Belperio PS; Hwang EW; Thomas IC; Mole LA; Cheung RC; Backus LI
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1021-7. PubMed ID: 23524130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.